Inhibition of formyl peptide receptor-1-mediated cell death as a therapy for lethal cutaneous drug reactions in preclinical models
Haruna Kimura(Niigata University), Riichiro Abe(University Hospitals of the Ruhr-University of Bochum)
Cited by 1
Related Papers
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
|The Journal of Immunology|2001|957
Faculty Opinions recommendation of Identification of drug-specific public TCR driving severe cutaneous adverse reactions.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2020|0